Biocon’s S&P Global ESG Score improves to 69 for 2024
Biocon’s subsidiary Biocon Biologics Limited, which also participated independently in the assessment for the first time, reported an S&P Global ESG Score of 53
Biocon’s subsidiary Biocon Biologics Limited, which also participated independently in the assessment for the first time, reported an S&P Global ESG Score of 53
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
The combination will support clients in getting their end-to-end discovery and development programs delivered.
India has a pivotal role in eliminating TB
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
The nadAROSE and nadia3D kits address the needs of researchers exploring both agarose encapsulation and collagen-based hydrogel projects for the 3D cell culture space.
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning
The report has estimated 4.74 million deaths for India in 2020 and 2021,
Subscribe To Our Newsletter & Stay Updated